Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases
Kartik Deshmukh, Arjun Khanna
Tuberc Respir Dis. 2021;84(1):35-45.   Published online 2020 Oct 13     DOI: https://doi.org/10.4046/trd.2020.0088
Citations to this article as recorded by Crossref logo
Evaluation of the Cardiac Status of Newly Diagnosed Chronic Obstructive Pulmonary Disease Patients at First Admission
Müfide Arzu Ozkarafakili, Mustafa İ Bardakci, Mutlu Cagan Sumerkan
Indian Journal of Respiratory Care.2024; 12(4): 308.     CrossRef
Prevalence and Risk Factors for Airflow Limitation in Patients With Acute Coronary Syndrome
Santiago Rodriguez-Segade Alonso, Carmen Diego Roza, Raquel Marzoa Rivas, Irene Nieto Codesido, Elvira Clavero Fernández, Félix Camiña, Santiago Rodriguez-Segade
Archivos de Bronconeumología.2023; 59(6): 397.     CrossRef
The Potential Important Role of Mitochondrial Rieske Iron–Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
Lillian Truong, Yun-Min Zheng, Yong-Xiao Wang
Biomedicines.2022; 10(5): 957.     CrossRef
Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease
Xiao-Fang Li, Cheng-Quan Wan, Yi-Min Mao
Frontiers in Medicine.2022;[Epub]     CrossRef
The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective
Kartik Deshmukh, Arjun Khanna
Tuberculosis and Respiratory Diseases.2021; 84(2): 167.     CrossRef
The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: a meta-analysis and systematic review
Zhiping Xu, Lingxia Zhu, Jingye Zhan, Lijun Liu
European Journal of Medical Research.2021;[Epub]     CrossRef